ArticlePLoS neglected tropical diseases2025
Exploring barriers to accessing treatment for Lymphatic Filariasis through a socio-ecological lens in Buvuma and Napak districts, Uganda.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Living with Filariasis: Unseen Struggles of a Neglected Disease.The Yale journal of biology and medicine · 2025Review
- Social and healthcare-seeking experiences of people affected with lymphedema in Bangladesh.PLoS neglected tropical diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe World Health Organization launched the Global Programme to Eliminate Lymphatic Filariasis in 2000, which aimed at eradicating the disease by 2030. This goal depends on community mass drug administration and essential care. Despite these efforts, many rural communities still face untreated lymphatic filariasis and lack access to treatment and self-management. Using a socioecological model, this study examined barriers to treatment and support for people living with lymphatic filariasis in Uganda's Buvuma and Napak districts.
methodsWe conducted 12 key informant interviews with health facility officials, district health officers, and village health team members. Additionally, 19 focus group discussions were held with community members, and nine in-depth interviews were conducted with people living with lymphatic filariasis. This study explored knowledge gaps among those living with lymphatic filariasis and health providers that affect morbidity management and disability prevention, as well as challenges in accessing treatment. Audio recordings were transcribed and managed via ATLAS ti software version 6. Thematic analysis was conducted via the socioecological model framework.
resultsThis study identified multiple complex factors affecting healthcare providers and individuals living with lymphatic filariasis, spanning individual, interpersonal, organisational, community, and policy levels. The key themes included stigma and social isolation, healthcare disparities, and healthcare dynamics. Stigma and social isolation result in emotional distress, neglect, exclusion, and self-isolation, which are influenced by community beliefs. Health systems and policy barriers included poverty, inadequate personnel, and insufficient equipment. Structural factors such as geographical remoteness, environmental harshness, and lack of healthcare infrastructure were prominent obstacles to seeking care for lymphatic filariasis management.
conclusionThis study provides insights into the multilevel factors influencing the understanding and availability of treatment for lymphatic filariasis in Uganda. Addressing sociocultural beliefs, social and interpersonal dynamics, and healthcare disparities is crucial for improving the outcomes and well-being of these rural communities. These findings can aid in managing lymphatic filariasis in Uganda and similar low-resource settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.